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Serotonin 5-HT2A receptors (5-HT2ARs) are widely distributed in the central nervous
system, especially in brain region essential for learning and cognition. In addition
to endogenous 5-HT, several hallucinogens, antipsychotics, and antidepressants
function by targeting 5-HT2ARs. Preclinical studies show that 5-HT2AR antagonists
have antipsychotic and antidepressant properties, whereas agonist ligands possess
cognition-enhancing and hallucinogenic properties. Abnormal 5-HT2AR activity is
associated with a number of psychiatric disorders and conditions, including depression,
schizophrenia, and drug addiction. In addition to its traditional activity as a G protein-
coupled receptor (GPCR), recent studies have defined novel operations of 5-HT2ARs.
Here we review progress in the (1) receptor anatomy and biology: distribution, signaling,
polymerization and allosteric modulation; and (2) receptor functions: learning and
memory, hallucination and spatial cognition, and mental disorders. Based on the recent
progress in basic research on the 5-HT2AR, it appears that post-training 5-HT2AR
activation enhances non-spatial memory consolidation, while pre-training 5-HT2AR
activation facilitates fear extinction. Further, the potential influence that 5-HT2AR-elicited
visual hallucinations may have on visual cue (i.e., landmark) guided spatial cognition
is discussed. We conclude that the development of selective 5-HT2AR modulators to
target distinct signaling pathways and neural circuits represents a new possibility for
treating emotional, neuropsychiatric, and neurodegenerative disorders.
Keywords: serotonin, 5-HT2A receptor, learning, memory, cognition
Introduction
The serotonin (5-HT) 5-HT2A receptor (5-HT2AR) is a GPCR of the type A family. It was deﬁned
as the classical D receptor initially by Gaddum and Picarelli (1957), and later referred as the 5-HT2
receptor by Peroutka and Snyder (1979). The 5-HT2AR gene is located on human chromosome
13q14-q21. HTR2A gene codes for a 471-amino acid sequence in rat, mouse, and human
Abbreviations: 5-HT, 5-hydroxytryptamine/serotonin; AD, Alzheimer disease; AMPAR, alpha-amino-3-hydroxy-5-methyl-
4-isoxazole propionate receptor; BLA, basolateral amygdala; CS, conditioned stimulus; DOI, 1-(2,5-dimethoxy-4-
iodophenyl)-2-aminopropane; ERK, extracellular signal-regulated kinases; GFAP, glial ﬁbrillary acidic protein; GPCR, G
protein-coupled receptor; IP; inositol phosphate; LSD; lysergic acid diethylamide; mGluR2, metabotropic glutamate receptor;
MUPP1, multiple PDZ protein-1; MWM, Morris water maze; NAc, nucleus accumbens; NMDAR, N-methyl-D-aspartate
receptor; NOR, novel object recognition; OCD, obsessive–compulsive disorder; PDZ, postsynaptic density zone; PFC,
prefrontal cortex; PKC, protein kinase C; PLC, phospholipase C; PSD, postsynaptic density; RSK2, ribosomal S6 kinase 2;
sIPSC, spontaneous inhibitory postsynaptic current; sIPSP, spontaneous inhibitory postsynaptic potential; US, unconditioned
stimulus.
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(Sparkes et al., 1991). The rat 5-HT2AR was cloned in
1988 (Pritchett et al., 1988) and the human 5-HT2AR was
reported by Julius et al. (1990). Central 5-HT2ARs exert diverse
behavioral, physiological, and psychological inﬂuences (Hoyer
et al., 2002; Hannon and Hoyer, 2008; Homberg, 2012).
Abnormality in the structure and function of the 5-HT2AR is
associated with a number of disorders, including schizophrenia,
depression/anxiety, and drug addiction. Furthermore, many
hallucinogenic drugs exert their psychoactive eﬀects by acting as
agonists for 5-HT2ARs. Preclinical studies show that 5-HT2AR
blockade has antipsychotic (Meltzer, 1999), antidepressant
(Kroeze and Roth, 1998; Roth et al., 1998) and anxiolytic
properties (Cohen, 2005). Pharmacological studies indicate that
high-aﬃnity antagonists of 5-HT2ARs are eﬀective atypical
antipsychotics, due to their demonstrated eﬃcacy to reduce
both positive and negative symptoms of schizophrenia. Results
from recent molecular biological and neuropharmacological
studies suggest some exciting potential new avenues by which
5-HT2ARs inﬂuence CNS function. Here we review progress
in understanding the contribution of 5-HT2ARs to modulation
of learning and memory through an analysis of their (1)
anatomy and biology: distribution, signaling, polymerization,
and allosteric modulation; and (2) functions: learning and
memory, hallucination and spatial cognition, and mental
disorders. Based on the recent progress in 5-HT2AR research,
we suggest that selective 5-HT2AR modulators targeting distinct
signaling pathways may hold signiﬁcant eﬃcacy as new
therapeutic approaches for several neurological disorders that
present with cognitive impairment.
5-HT2AR Anatomy and Biology in CNS
Cellular and Subcellular Distribution
Serotonin 5-HT2ARs are widely distributed in the CNS. In the
rat brain, immunohistochemical studies show that 5-HT2ARs
are broadly expressed in the cerebral cortex – especially in
layers I and IV–V, the piriform and entorhinal cortex, the
claustrum, endopiriform nucleus, and olfactory bulb/anterior
olfactory nucleus, brainstem, as well as the limbic system and the
basal ganglia; especially in the NAc and caudate nucleus (Xu and
Pandey, 2000; Hannon and Hoyer, 2008). Interestingly, 5-HT2AR
binding appears to be absent from cerebellum (Xu and Pandey,
2000).
In human brain, autoradiographic analysis using [3H]
ketanserin indicates a high density of 5-HT2AR binding in
laminae III and V of the frontal, parietal, temporal, occipital,
anterogenual cortexes, and entorhinal area. 5-HT2ARs are also
visualized in the mammillary bodies of the hypothalamus,
claustrum, and the lateral nucleus of the amygdala. The
hippocampus, caudate, putamen, and accumbens nuclei present
an intermediate density of binding. Areas such as the thalamus,
brain stem, cerebellum and spinal cord contained only low to very
low densities of binding (Pazos et al., 1987). In situ hybridization
studies reveal that 5-HT2AR mRNA is present in all neocortical
areas, especially in layer 5 pyramidal neurons, and in putative
interneurons. 5-HT2AR mRNA was observed at minimal levels
in the hippocampus and not in the raphe, cerebellum, substantia
nigra or striatum (Burnet et al., 1995).
Morphological and double immunoﬂuorescence analyses
conﬁrmed the presence of 5-HT2ARs on pyramidal neurons,
interneurons, and glial cells in neocortex, amygdala and
hippocampus (Willins et al., 1997; Bombardi, 2012, 2014). Thus,
predicting the functional inﬂuence of activated cortical 5-HT2ARs
is not straightforward, since these receptors would be capable
of direct excitation and modulating feed-forward inhibition.
In addition, 5-HT2ARs are located on cholinergic (Quirion
et al., 1985) and glutamatergic neurons (Hasuo et al., 2002).
5-HT2AR immunolabeling was also observed on glial cells in
many forebrain regions: astrocytes were identiﬁed by double
immunolabeling as cells in which 5-HT2AR and GFAP was
colocalized (Xu and Pandey, 2000); and on microglia (Glebov
et al., 2015). These ﬁndings demonstrate that consideration of
the serotonin-mediated signaling at 5-HT2ARs must include
pathways that involve neurons and glial cells alike. It will be of
interest to determine the degree to which functional inﬂuences
expressed by the activation of 5-HT2ARs are dependent upon
neurons, astrocytes, and microglial cells, and to determine
whether clinically relevant features of 5-HT2ARs are related to
changes in neurons or astrocytes.
At the subcellular level, 5-HT2AR immunolabeling is found
on cell bodies and processes of neurons (Cornea-Hebert et al.,
1999; Xu and Pandey, 2000); in particular, at both pre- and
post-synaptic compartments (Miner et al., 2003). However, the
majority of evidence suggests a predominant expression at
postsynaptic dendritic spines and shafts of non-5-HT neurons.
Our own immuno-electron microscopy data revealed that 5-
HT2AR is also distributed in the dendritic spines, shafts, and
presynaptic terminals of CA1 neurons in the mouse dorsal
hippocampus (Zhang et al., 2015). Consideration should also
be given to evidence suggesting that 5-HT2AR subunits are
extensively and dynamically traﬃcked between the cytoplasm
and the neuronal membrane, as much 5-HT2AR label has
been identiﬁed at cytoplasmic rather than membrane bound
compartments in adult rat neocortex (Cornea-Hebert et al.,
1999). It will be of interest to determine the corresponding
function of 5-HT2AR subunit traﬃcking between the respective
neuronal sub-compartments, and the intracellular signaling that
promotes traﬃcking.
Interacting Proteins
Multiple interacting proteins regulate the function of 5-HT2ARs
in the membrane. 5-HT2ARs interact with multiple PDZ protein-
1 (MUPP1) and PSD-95 PDZ proteins (Jones et al., 2009).
The 5-HT2AR colocalizes with PSD-95 and with MUPP1 in a
subset of dendritic spines of rat cortical pyramidal neurons.
PDZ proteins are vital for docking 5-HT2AR to the dendrites in
cortical neurons and preventing the internalization of 5-HT2ARs
(Xia et al., 2003). MUPP1 is enriched in dendritic spine PSD
domains of pyramidal neurons and enhances the localization
of 5-HT2AR to the cell surface. Within cortical pyramidal
neurons, PSD-95 regulates the functional activity of 5-HT2AR
by promoting apical dendritic targeting and stabilizing receptor
turnover. The complex of 5-HT2AR and PSD-95 plays a key
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role in 5-HT2AR-mediated head-twitch behavior in mice (Abbas
et al., 2009). Binding of calmodulin to the 5-HT2AR C-terminus
impedes PKC-mediated phosphorylation of the 5-HT2AR, thus,
preventing its desensitization (Turner and Raymond, 2005).
Conversely, association of p90-RSK2 with 5-HT2AR (intracellular
3 loop) silences the GPCR’s signaling (Sheﬄer et al., 2006).
Caveolin-1 interacts with 5-HT2AR and profoundly modulates
its signaling by facilitating the interaction of 5-HT2AR with Gαq
(Bhatnagar et al., 2004). 5-HT2AR and the light chain 2 domain
of the microtubule-associated protein MAP1A are co-localized in
the intracellular compartment of pyramidal neuronal dendrites
of adult rats and may participate in intraneuronal signaling
processes involving cytoskeletal elements (Cornea-Hebert et al.,
2002). In consideration of these properties, we suggest that
altering 5-HT2AR-coupled proteins and pathways may enable an
alternative method to selectively promote distinct modulatory
functions of 5-HT2ARs.
Signaling
Activation of neuronal 5-HT2ARs can induce pleiotropic
eﬀects via G protein-dependent, ligand-dependent, and ligand-
independent signaling pathways, including phospholipase
signaling, ERK pathway, and tyrosine kinase pathway in neurons
(Millan et al., 2008; Masson et al., 2012). In most circumstances,
activation of 5-HT2ARs increases intracellular Ca2+ levels via
Gαq-PLC-IP3 signaling (Hagberg et al., 1998). In PFC, activation
of 5-HT2ARs suppresses membrane Cav1.2 L-type Ca2+ currents
via a Gαq-mediated PLCβ/IP3/calcineurin signaling pathway
(Day et al., 2002). 5-HT2AR activation also stimulates the
Gα12/13-phospholipase A2 signal transduction pathway, which
promotes arachidonic acid release (Kurrasch-Orbaugh et al.,
2003a,b).
Besides PLC-mediated Ca2+ signaling, 5-HT2AR activation
also induces ERK phosphorylation via diverse intracellular
signaling mechanisms (Gooz et al., 2006). Src and calmodulin
promote 5-HT2AR-mediated phosphorylation of ERK. In the
PC12 cell model system, ERK phosphorylation by 5-HT2AR
may not depend on PLC/PKC signaling, and instead requires
an increase in intracellular Ca2+, and the activation of CaM
and Src (Quinn et al., 2002). The ERK target RSK2 directly
acts on the third intracellular (i3) loop of 5-HT2AR protein
(Sheﬄer et al., 2006), leading to direct phosphorylation of the
i3 loop at the conserved residue Ser-314 to suppress 5-HT2AR
signaling. In addition, RSK2 is required for tyrosine kinases, such
as the epidermal growth factor receptor and the platelet-derived
growth factor receptor, both of which have been demonstrated
to attenuate 5-HT2AR functioning in primary cortical neurons
(Strachan et al., 2009, 2010).
Besides the G protein, 5-HT2ARs are also coupled to
β-arrestin2. 5-HT binds 5-HT2AR to stimulate Akt
phosphorylation via the β-arrestin2/phosphoinositide 3-
kinase/Src/Akt cascade (Schmid and Bohn, 2010). Application of
the 5-HT2AR agonist DOI to cultured cortical neurons induced
phosphorylation of p21-activated kinase (PAK) via Rac guanine
nucleotide exchange factor (RacGEF) kalirin-7 (Jones et al.,
2009). The 5-HT2AR also regulates the tyrosine kinase pathway
activity (Quinn et al., 2002). Excitation of neuronal 5-HT2ARs
activates transglutaminase which leads to transamidation of
Rac1, a small G protein, resulting in constitutive activation of
Rac1 (Dai et al., 2008). Chronic treatment with olanzapine,
an atypical antipsychotic drug, causes the desensitization
of 5-HT2AR signaling. In rat frontal cortex, stimulation of
the JAK-STAT pathway desensitizes the 5-HT2AR-mediated
PLC activation induced by olanzapine (Singh et al., 2010).
Furthermore, constitutive activation of 5-HT2ARs induces Gq/11
phosphorylation and desensitization (uncoupling) (Shi et al.,
2007).
As indicated above, 5-HT2ARs are also expressed in microglia
and mediate 5-HT-induced exosome release (Glebov et al., 2015).
Activation of 5-HT2AR increases intracellular Ca2+ via PLC
signaling in astrocytes (Hagberg et al., 1998) and Glu eﬄux from
C6 glioma cells (Meller et al., 2002). Considering the diversity of
signaling cascades that can be triggered by 5-HT2AR activation,
it is perhaps not surprising that serotonergic activation of 5-
HT2ARs can have diverse inﬂuences on neuronal responses and
CNS functions.
Oligomerization
The GPCRs can form homomers and heteromers, and thereby
present distinct signaling and functional activities (Rios et al.,
2001). Consistent with this, 5-HT2ARs have been shown to form
oligomers (Lukasiewicz et al., 2010). Fluorescence resonance
energy transfer and immunoprecipitation studies revealed that
the human 5-HT2AR homodimerizes in cultured cells (Brea
et al., 2009). For 5-HT2AR oligomers, the 5-HT2AR agonist DOI
caused an increase in energy transfer eﬃciency to the level of
12%, and ketanserin caused a decrease of 4.4%. Heterodimers
of 5-HT2AR and dopamine D2 receptors respond to DOI
and quinpirole, a DA D2R agonist, with a decrease in FRET
eﬃciency, while ketanserin and butaclamol increase the transfer
eﬃciency value (Lukasiewicz et al., 2010). Heterodimers of 5-
HT2AR and mGluR2 receptor form via the linking domain in
transmembrane-4 and -5 segments, and are present in the human
brain. Post-mortem studies indicate a reduced density of these
functional complexes in brains of schizophrenics (Gonzalez-
Maeso et al., 2008). Delta-9-tetrahydrocannabinol (THC), the
main psychoactive compound of marijuana, induces memory
impairments, anxiety, dependence, and analgesia. Vinals et al.
(2015) recently reported that amnesic and anxiolytic eﬀects, but
not analgesia, induced by THC were suppressed in 5-HT2AR
knockout mice. Molecular studies revealed that cannabinoid CB1
receptors (CB1R) and the 5-HT2AR physically interact with each
other to form heteromers, which are distributed extensively in
hippocampus, cortex, and dorsal striatum, but not in the NAc.
In vivo experiments have revealed that stimulation of CB1R
and 5-HT2AR reduces cell signaling, and the binding of an
antagonist to one receptor blocks signaling of the interacting
receptor. Heteromer formation leads to a switch in 5-HT2AR-
mediated G-protein coupling from Gαq to Gi. Synthetic peptides
with the sequence of transmembrane helices 5 and 6 of CB1R
disrupt CB1R and 5-HT2AR heteromerization in vivo, leading
to a selective abrogation of memory impairments, but not the
antinociceptive properties caused by THC exposure (Vinals
et al., 2015). The anatomy, biology and function of 5-HT2AR
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homomers and heteromers, including the dynamic formation
and dissociation, distribution, signaling and function, remain
elusive. Elucidation of 5-HT2AR oligomers will be interesting for
both basic science research and potential clinical applications.
Allosteric Modulation
Recent years have witnessed a tremendous advance in the
research and development of novel compounds for GPCRs
that bind allosteric sites to regulate receptor structure and
function. These ligands provide high speciﬁcity, novel modes of
eﬃcacy and may open up a novel avenue for therapeutic agents
against multiple mental and neurological disorders. Allosteric
modulators bind to a site distinct from that of the orthosteric
ligand-binding site. Usually the allosteric modulator induces
a structure change within the GPCR to enhance or suppress
the orthosteric ligand’s functional activity (Conn et al., 2009;
Melancon et al., 2012). Application of the amidated lipid,
oleamide signiﬁcantly potentiated 5-HT-induced hydrolysis of
phosphoinositide in pituitary P11 cells expressing endogenously
5-HT2ARs (Thomas et al., 1997). Taken together, these results
indicate that there are several binding sites present on 5-HT2ARs,
and we suggest that it will be of interest to further characterize the
functional signiﬁcance of the distinct ligand-driven actions at the
5-HT2AR.
Constitutive Activity
As mentioned above, 5-HT2ARs can also be constitutively active
(i.e., via activating the receptor in an agonist-independent
activity) in vivo (Berg et al., 2008). The inverse 5-HT2AR
agonists (e.g., risperidone and ketanserin) produce a great
suppression of basal IP production, leading to a reduction of
basal activity in the C322K mutant 5-HT2AR (Egan et al.,
1998). The “constitutively active” arrestin mutant (Arr2-R169E)
induces agonist-independent 5-HT2AR internalization, and a
constitutive translocation of the Arr2-R169E mutant to the
plasma membrane (Gray et al., 2003). The constitutive activity
of 5-HT2ARs may represent another mechanism of regulating
cellular function. The speciﬁc relationships of these constitutively
active 5-HT2AR-mediated properties to distinct behaviors have
not been determined.
Electrophysiological Characteristics
Electrophysiological studies reveal complex eﬀects of 5-HT2AR
activation on cortical neurons; however, mainly these receptors
appear to mediate depolarizing eﬀects on excitatory and
inhibitory neurons. Slice recordings from prefrontal cortical
neurons indicate depolarizing eﬀects following 5-HT2AR
activation (Aghajanian and Marek, 1999; Zhou and Hablitz,
1999; Avesar and Gulledge, 2012). Local application of DOI,
a 5-HT2A/2C receptor agonist, increases the ﬁring rates of
cortical neurons (Stein et al., 2000) and facilitates synaptic
plasticity through an NMDAR-dependent mechanism in
presumptive pyramidal neurons of the rat BLA (Chen et al.,
2003). Meanwhile, α-methyl-5-hydroxytryptamine (a 5-HT2R
agonist) and DOI induce activation of GABAergic interneurons
of the rat BLA (Stein et al., 2000). Double immunoﬂuorescence
labeling demonstrated that the 5-HT2AR is primarily localized
to parvalbumin-containing BLA interneurons. Accordingly,
5-HT primarily acts on 5-HT2ARs to potentiate GABAergic
inhibition. 5-HT2AR activation increases the frequency and
amplitude of sIPSCs recorded from the pyramidal neurons in
BLA of the juvenile rat (Jiang et al., 2009). DOI potentiates
NMDAR-mediated changes in membrane potentials and
calcium inﬂux without aﬀecting the neuronal resting membrane
potential or input resistance. However, DOI does not aﬀect
AMPA/kainate receptor-mediated excitatory synaptic responses
(Chen et al., 2003). The relationship of 5-HT2ARs to NMDARs
is consistent with the view that 5-HT2ARs may be an eﬀective
target for modulating experience-dependent synaptic plasticity
in the CNS. Globally, 5-HT2ARs have been shown to inﬂuence
low-frequency ﬁeld potential oscillations in rat frontal cortex
(Celada et al., 2008). Taken together, these ﬁndings demonstrate
that the 5-HT2AR mediates 5-HT-induced excitation of
cortical neurons. However, much remains to be determined
as to the neurophysiological consequences of 5-HT2AR
activation, in particular as they relate to the regulation of
speciﬁc behaviors.
Recent molecular and pharmacological research has made
signiﬁcant advances in the understanding of the functional
selectivity of 5-HT2AR. The multiple signaling pathways suggests
bias agonism and bias signaling of 5-HT2ARs, which posit that
an agonist can produce a mix of signaling, which is potentially
determined by cell type and functional status.
5-HT2AR Functions in CNS
Long-term declarative or episodic memory is supported by a
network of brain structures in the medial temporal lobe of the
mammalian brain. The medial temporal lobe memory system,
which includes the hippocampus, dentate gyrus, and surrounding
extrahippocampal cortical regions, inﬂuence decision-making
processes guided by the PFC, and posterior parietal cortex
(Squire et al., 2004, 2007; Preston and Eichenbaum, 2013).
Serotonergic ﬁbers originating from the raphe nuclei innervate
many of the critical nodes within the medial temporal lobe
memory system, including the hippocampus and amygdala,
and on to the PFC (Vertes, 1991; Vertes et al., 1999). The
modulatory inﬂuence of 5-HT on simple and more complex
forms of learning and memory has been extensively examined
in both invertebrate and vertebrate model systems (Kandel and
Squire, 2000). The relevance of 5-HT to memory seems to
generalize across mammals:, dietary tryptophan increases brain
5-HT levels and improves memory in rodents (Khaliq et al.,
2006), the elderly, AD patients, and schizophrenics (Levkovitz
et al., 2003; Porter et al., 2003). Further, reductions in brain 5-
HT concentrations after acute or chronic tryptophan depletion
has been demonstrated to impair contextual fear memory in
mice (Uchida et al., 2007), object memory in rats (Jenkins
et al., 2009), and declarative memory in humans (Schmitt
et al., 2006). Below, we describe some evidence suggesting
that the 5-HT2AR may hold special signiﬁcance as one of
the substrates by which 5-HT regulates learning and memory
(Meneses, 2007).
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Learning and Memory
Polymorphisms in the human HTR2A gene are associated
with altered memory processes. For example, a HTR2A gene
polymorphism inducing the substitution of the His452 on the
receptor subunit to a Tyr residue is associated with a signiﬁcant
impairment in memory recall amongst adults (de Quervain et al.,
2003; Sigmund et al., 2008; Zhu et al., 2013). Carriers of the
His452Tyr (rs6314) exhibited poor verbal delayed recall and
recognition, but performed equivalent to controls on tests of
immediate recall, attentional, and executive function (Wagner
et al., 2008). Compared to His homozygotes, Tyr carriers
exhibited a diminished hippocampal response to novel stimuli
and a higher tendency to judge novel stimuli as familiar during
delayed recognition (Schott et al., 2011). Amongst schizophrenics
and healthy controls, those carriers of homozygous CC (T102C)
and GG (A-1438G), or carriers of the so-called T-allele (rs6314),
of the HTR2A gene polymorphisms exhibited signiﬁcantly
impaired short-term verbal memory (Alﬁmova et al., 2009),
and spatial working memory (Blasi et al., 2013). Another
polymorphism in the HTR2A gene, referred to as rs4941573 was
found to be predictive of increased error rate in a spatial working
memory task in an adult Chinese subject population (Gong et al.,
2011). These results provide just a brief and incomplete view
of a broad literature indicating the impressive degree to which
alterations in the HTR2A gene relate to disordered cognitive
functions in normal and abnormal human subjects.
The regional distribution of 5-HT2ARs can be predictive of the
memory capacities that are sensitive to serotonin manipulation.
The 5-HT2ARs are widely expressed in the neocortex and
hippocampus of rats (Xu and Pandey, 2000; Hannon and
Hoyer, 2008), rabbits (Aloyo and Harvey, 2000), primates (Jakab
and Goldman-Rakic, 1998; Lopez-Gimenez et al., 1998), and
humans (Hoyer et al., 1986; Lopez-Gimenez et al., 1998).
Table 1 summarizes the major ﬁndings of studies in which
the learning and memory eﬀects were examined after 5-HT2AR
pharmacological manipulations across distinct tasks and diﬀerent
species. The inconsistency of experimental results may be
attributed to the species, selectivity and dose of drug, behavioral
task and other eﬀectors.
Object Memory
The spontaneous NOR task, which relies on rodents’ inherent
preference for exploring novel over familiar stimuli, has become
a popular method for examining the neuropharmacological and
neurophysiological mechanisms of object memory (Ennaceur,
2010; Cohen and Stackman, 2015). In the task, rodents are
exposed to one or two novel objects in a familiar enclosure
during a sample session (i.e., training). The rodent is removed
from the enclosure after it has suﬃciently explored the objects.
After a delay of some length, the rodent is returned to the
enclosure for a memory test session, during which the enclosure
contains one familiar object and a novel object. If the rodent
has successfully encoded and consolidated the memory of the
original object from the sample session, then it is expected that
the rodent will preferentially explore the novel object during the
test session. The NOR task oﬀers advantages for testing rodent
memory in that the distinct memory processes of encoding,
consolidation and retrieval are operationally deﬁned as events
occurring during the sample session, after the sample session, or
during the test session, respectively. Another advantage is that
the behavioral responses are spontaneous rather than requiring
overt motivation such as electrical shock or food restriction.
Our recent studies implicate the hippocampus as a key region
in the rodent brain for object memory processes (Cohen et al.,
2013; Cohen and Stackman, 2015). In light of the fact that 5-
HT2ARs are densely expressed in the hippocampus (Luttgen et al.,
2004), we examined the contribution of hippocampal 5-HT2ARs
in object memory processes in male mice using an NOR task
(see Figure 1). Systemic activation of 5-HT2ARs with the selective
agonist, TCB-2 after the sample session signiﬁcantly enhanced
the time mice spent exploring the new object presented during
the test session 24 h later (Zhang et al., 2013). The memory-
enhancing eﬀect of TCB-2, was blocked by pretreatment with
the 5-HT2AR antagonist, MDL 11,939, which suggests that 5-
HT2AR activation enhances the consolidation of object memory.
Interestingly, when TCB-2 was administrated before the sample
session, or before the test session, the 5-HT2AR agonist failed to
increase novel object preference relative to the respective control
group. Together, these data suggest that 5-HT2AR activation
selectively potentiates memory consolidation. Furthermore, the
selective local microinfusion of TCB-2 into the CA1 region of
dorsal hippocampus recapitulated the memory enhancing eﬀect
observed after systemic treatment (Zhang et al., 2015). The
relevance of the 5-HT2AR for object memory processes was also
demonstrated by results of a study showing that the local infusion
of the 5-HT2AR antagonist MDL 11,939 into the mPFC impaired
retrieval of object-in-context memory in rats (Bekinschtein et al.,
2013). Interestingly, the 5-HT2AR agonist DOI was found to
impair retrieval of memory for an operant response by adult
rats in an autoshaping task (Meneses, 2007). Thus, it would
appear that the inﬂuence of the 5-HT2AR on memory is task-
and memory system-dependent, and perhaps by the underlying
neural circuitry that supports the respective memory process.
The encoding and consolidation of hippocampal-dependent
memory appears, in part, to require fast glutamatergic
neurotransmission, ensuing phases of synaptic plasticity,
and dynamic replay of experience-dependent neurophysiological
oscillatory activity within hippocampal cell populations
(Eichenbaum, 1999; Karlsson and Frank, 2009). Our published
(Zhang et al., 2013) data show that post-training activation
of 5-HT2AR s enhances object memory, likely by aﬀecting
consolidation. Prevailing views state that the hippocampus
transfers recent to-be-remembered information to the neocortex
during sharp wave ripples of the hippocampal local ﬁeld
potential (i.e., 100–200 Hz ripples; Chrobak and Buzsaki,
1996; Carr et al., 2011). During sleep, hippocampal neurons
‘replay’ patterns of spike trains present during a learning
episode. As sharp wave ripples and replay may represent
systems consolidation of memory, it would be of interest to
examine the inﬂuence of 5-HT2AR-sensitive drugs on sharp
wave ripples and replay of spiking sequences during sleep
episodes after a to-be-remembered experience. Postsynaptic
5-HT2ARs may modulate object memory consolidation by also
inﬂuencing NMDAR-mediated synaptic plasticity. Consistent
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TABLE 1 | Reported effects on learning and memory after pharmacological manipulation of 5-HT2A receptors (5-HT2ARs).
Drug Route; dose Task Species Effect Reference
M100907 0.01–0.1 mg/kg; i.p. Probabilistic reversal learning Mice ↑Acquisition Amodeo et al., 2014;
∗BTBR T+tf/J mouse
model of autism
M100907 0.01–0.1 mg/kg; i.p. Serial spatial reversal learning
task
Rats ↓ Retrieval Boulougouris et al.,
2008
M100907 0.02–2.0 nmol; olfactory
bulb
Reversal-learning task Rats ↓ Acquisition Furr et al., 2012
MDL 11,939 0.067–6.7 μmol/kg; s.c. Nictitating membrane
conditioned responses
Rabbits ↓ Acquisition Welsh et al., 1998
MDL 11,939 300 ng/μl; mPFC NOR task Rats ↓ Retrieval Bekinschtein et al.,
2013
Ritanserin, 2.5 mg/kg × 11 days; s.c. Conditioned olfactory training Rat pup ↑ Acquisition McLean et al., 1996
Risperidone 1 mg/kg; i.p. Reward-dependent operant
conditioning task
Rats ↓ Acquisition and ↑ extinction Frick et al., 2015
Risperidone 0.125 mg; i.p. Probabilistic reversal learning B6 mice ↓ Acquisition Amodeo et al., 2014
Ketanserin Methysergide 1.0–3.0 mg/kg; s.c.;
3.0–15.0 mg/kg; i.p.
Delayed non-matching to
position task (working memory)
Rats ↔ Retrieval Ruotsalainen et al.,
1997
Ketanserin 0.1 mg/kg × 14 days; i.p. Passive avoidance paradigm
and MWM
Rats ↓ Acquisition Fedotova and Ordyan,
2010
DOI Ketanserin 0.01–0.1 mg/kg; i.p.
0.001–0.1 mg/kg, i.p.
Autoshaping learning task Rats ↑ Consolidation Meneses et al., 1997
M100907;α-methyl-5-HT PFC Oculomotor delayed-response
tasks
Monkeys ↓ Acquisition
↑ Acquisition
Williams et al., 2002
TCB-2 1.0 mg/kg; i.p. NOR task and Trace and delay
fear conditioning
Mice ↑ Object memory acquisition;
↑fear memory extinction
Zhang et al., 2013
DOI 0.1–0.3 mg/kg; i.p. Autoshaping learning task Rats ↓ Consolidation Meneses, 2007
LSD 0.43–12.9 μg/side;
hippocampus
Trace eyeblink conditioning. Rabbits ↑ Acquisition Romano et al., 2010
LSD 1–300 nmol/kg; i.v. Nictitating membrane response Rabbit ↑ Acquisition Gimpl et al., 1979
LSD 0.13 mg/kg/d × 11 days;
s.c.
Bulbectomy-induced deficit in
active avoidance learning
Rats ↑ Acquisition Buchborn et al., 2014
Psilocybin 215 μg/kg; oral Spatial working memory task Humans ↔ Retrieval Carter et al., 2005
Psilocybin 0.1–1.5 mg/kg, i.p. Trace fear conditioning - mice ↑ Extinction Catlow et al., 2013
Psilocin 1.0 mg/kg, i.p.
4.0 mg/kg, i.p.
MWM;
Carousel maze (CM)
Rats ↓Acquisition of CM;
↓Retrieval of MWM (4 mg/kg);
↔ Consolidation
Rambousek et al., 2014
Quipazine 1.25–10 mg/kg, s.c. Conditioned avoidance
response
Rats ↑ Acquisition Alhaider et al., 1993
↑, enhance; ↓, suppress; ↔, no effect.
with this possibility, hippocampal 5-HT2ARs are predominantly
expressed at dendritic sites on pyramidal neurons (Cornea-
Hebert et al., 1999; Peddie et al., 2008). 5-HT2AR-containing
dendritic processes also were immunolabeled for the NMDAR
subunit NR1 and GluR2 (Peddie et al., 2008). We have found
that 5-HT2AR activation increased the extracellular eﬄux of
glutamate in the dorsal hippocampus, and increased the basal
ﬁring rates of CA1 pyramidal neurons in awake behaving mice
(Zhang et al., 2015). These results suggest that the 5-HT2AR
activation induced facilitation of object memory consolidation,
may result from the potentiation of hippocampal glutamate
release, and pyramidal neuron temporal dynamics at a critical
post-training time period. These data suggest that the 5HT2AR
may serve as a drug target for pharmacological interventions
to treat memory impairments. It is conceivable that 5-HT2AR
activation promotes an increase in intracellular Ca2+, combined
with NMDAR-mediated Ca2+ inﬂux, which together would
facilitate the behavior-initiated synaptic plasticity. Aghajanian
and Marek (1999) reported that activation of 5-HT2AR produces
an elevation in the frequency and amplitude of neuronal
sEPSP/sEPSC. Consistently, 5-HT2AR activation has been shown
to facilitate NMDAR activity and synaptic plasticity in the cortex
(Arvanov et al., 1999) and BLA (Chen et al., 2003). Furthermore,
5-HT2AR directly interacts with PSD-95 to regulate receptor
traﬃcking and signaling (Xia et al., 2003). 5-HT2AR activation
induces a transient increase in dendritic spinogenesis (Yoshida
et al., 2011), phosphorylation of PAK, neuronal Rac guanine
nucleotide exchange factor (Jones et al., 2009), BDNF expression
(Vaidya et al., 1997), and Erk mitogen-activated protein kinase
activity (Florian and Watts, 1998; Watts, 1998). Finally, the
5-HT2AR inverse agonist pimavanserin was shown to reverse
NMDAR antagonism-induced object memory impairments in
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FIGURE 1 | Activation of 5-HT2ARs enhances the consolidation of object memory. (A) Experimental strategy. Left, during the sample session, mice were
allowed to explore two identical novel objects each for at least 15 s, or either one for 18 s within a 10-min sample session. Middle, during the test session 24 h later,
one of the objects (a cabinet leveling foot) was replaced with a novel object (a plastic toy monkey) and mice were individually reintroduced to the arena. Right, the
objects used in this study. (B) There was no difference in the latency to achieve exploration criteria during the sample session between the saline- and TCB-2-treated
mice. (C) Mice that received TCB-2 right after the sample session exhibited a significantly stronger preference for exploring the novel object during the test session:
analysis revealed that TCB-2-treated mice had a higher mean discrimination ratio as compared to that of the saline group. (D) MDL 11,939, a selective 5-HT2AR
blocker suppressed TCB-2-induced enhancement in object memory (Zhang et al., 2013). ∗p < 0.05, vs. respective control condition.
combination with atypical antipsychotic drugs (Snigdha et al.,
2010). These results support the view of a modulatory inﬂuence
of 5-HT2AR on NMDAR-dependent memory mechanisms.
Considering the myriad potential inﬂuences of 5-HT2AR on
medial temporal lobe memory mechanisms, there would appear
to be multiple downstream inﬂuences by which 5-HT2AR
activation could enhance memory.
Fear Memory
While there is a rich literature on the inﬂuence of serotonin on
anxiety and an established contribution of serotonergic drugs
to the remediation of anxiety disorders in humans, the present
review will focus on the inﬂuence of 5-HT2ARs on fear memory
encoded during Pavlovian conditioning sessions. Pavlovian fear
conditioning has become a popular procedure for examining
the neurobiological mechanisms of fear memory. As a Pavlovian
conditioning procedure, fear conditioning lends itself well to
deﬁning processes of encoding, consolidation and retrieval of
fear memory. Fear conditioning taxes a well-deﬁned neural
circuit within the amygdala, which in turn interacts with the
hippocampus, anterior cingulate, or the PFC, depending on the
elements of the conditioning session and the stage of memory
processing (Zelikowsky et al., 2014). In addition, considerable
attention has been given to investigations of the underlying
biology of extinction of fear memory. During a delay fear
conditioning session, an innocuous stimulus (e.g., a neutral
tone or light) becomes a CS when it is repeatedly presented
in such a way that it co-terminates with the presentation
of a suﬃciently aversive US (e.g., foot shock) (Zhang et al.,
2013). The unconditioned response to the foot shock US is
typically jumping and running, but the conditioned response
to the CS is a defensive freezing response, or the cessation
of all movement except for respiration. Thus, the freezing
behavior provides a reliable post-conditioning measure of fear
memory in rodents (Blanchard and Blanchard, 1969). During
fear conditioning, the subject learns to associate the tone CS
with the foot shock US, and under certain conditions, learns
to associate the foot shock with the environment or context
where the conditioning session was presented. Acquisition of
both the tone-shock and the context-shock associations requires
the amygdala; however, the context-shock associations are also
dependent upon the hippocampus (Kim and Fanselow, 1992;
Phillips and LeDoux, 1992). There has been considerable debate
regarding the involvement of the hippocampus in contextual
fear memory since there have been reports that hippocampal
lesions impair contextual fear memory (Kim and Fanselow, 1992;
Phillips and LeDoux, 1992; Anagnostaras et al., 1999; Stiedl et al.,
2000), and others reporting that such lesions spare contextual
fear memory (Cho et al., 1999; Wiltgen et al., 2006). Consensus
seems to be building for the view that if the rodent is permitted
suﬃcient time to acquire a hippocampal-dependent conﬁgural
representation of the context (the chamber’s geometry, olfactory,
visual, tactile, and auditory cues) before the US is presented,
then the hippocampus is engaged in associating the contextual
memory with the foot shock (Rudy et al., 2002, 2004;Matus-Amat
et al., 2004; Zelikowsky et al., 2014). In a trace fear conditioning
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FIGURE 2 | Stimulation of 5-HT2ARs enhances the acquisition of extinction of trace fear memory. (A) Left, a chamber for fear conditioning (Context A) and
contextual fear memory test; right, Context B, a modified chamber with different color, context, light density, and odor for cued fear memory test. (B) Trace fear
conditioning training procedure. After a 60-s habitation to Context A, a tone was presented for 15 s followed by 30 s stimulus-free interval, and then a 0.5-s,
0.75 mA foot shock (US) was presented. The CS–US pairing was repeated eight times with a 210-s intertrial interval (ITI). Mice were removed from the conditioning
chamber and returned to their home cages 60 s after the final CS–US pairing. Trace fear conditioning extinction procedure. Sixty seconds after placing the mouse
into the modified chamber, eight unpaired 15-s tone CS were presented with a 120-s ITI. (C) Mice that received TCB-2 (1.0 mg/kg, i.p.) before a trace fear memory
extinction test exhibited accelerated acquisition of extinction as indicated by significantly lower freezing scores earlier in the course of extinction as compared to
those of vehicle-treated mice. TCB-2 significantly decreased percent freezing from the second to eighth CS presentation (Zhang et al., 2013).
procedure, a temporal gap is imposed between the oﬀset of the
tone CS and the onset of the foot shock US. The acquisition of
an appropriately timed (i.e., anticipatory) conditioned freezing
response occurs progressively over the course of the repeated
CS–US pairings; this temporal fear memory is a form of
declarative memory dependent on intact hippocampal function
in rodents and humans (Clark and Squire, 1998; McEchron
et al., 1998; Chowdhury et al., 2005). It should be clear that
in deciphering an inﬂuence of 5-HT2AR-sensitive drugs on the
distinct processes of memory for contextual and/or cued fear,
one must consider the speciﬁcs of the conditioning protocol
used.
Finally, considerable attention has been directed toward
deﬁning the mechanisms of fear memory extinction, in part
because of extinction’s potential relationship to components of
the human disorder post-traumatic stress disorder (Jovanovic
and Ressler, 2010). Repeated presentations of the CS alone to
the fear-conditioned rodent, promotes the acquisition of a new
inhibitory association, which dampens or completely suppresses
the expression of conditioned fear responses. Distinct subregions
of the rodent PFC contribute diﬀerentially to fear extinction;
that is, the prelimbic cortex appears to inﬂuence the expression
of fear responses, while the infralimbic cortex inﬂuences the
acquisition of extinction of fear memory (Quirk et al., 2010;
Sierra-Mercado et al., 2011). Synaptic plasticity within mPFC-
BLA neuronal circuits is induced during fear extinction training,
resulting in increased inhibition of CS-elicited activity of BLA
extinction neurons (Herry et al., 2008, 2010). Thus, converging
evidence implicates the infralimbic and prelimbic cortices of
the rodent brain and their diﬀerential projections to the
amygdala sub-regions and to the hippocampus as contributing
signiﬁcantly to the synaptic plasticity that develops during the
acquisition of fear extinction (see Tovote et al., 2015 for a recent
review).
We found that systemic administration of the 5-HT2AR
agonist TCB-2 (see Figure 2) signiﬁcantly enhanced the
acquisition of fear extinction in mice that had undergone trace
fear conditioning or delay fear conditioning (Zhang et al., 2013).
Importantly, the 5-HT2AR agonist did not aﬀect locomotor
responses or baseline freezing in the mice. Therefore, the
eﬀect of TCB-2 on fear extinction appeared to be speciﬁc to
facilitating the acquisition of the new inhibitory memory that
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suppressed fear expression. It is of interest to determine the
site of action in the rodent brain at which TCB-2 works to
facilitate fear extinction. In light of the plastic changes in neural
circuitry that occur during the acquisition of fear extinction,
it is possible that TCB-2 inﬂuences either the infralimbic
cortical neurons or the “extinction neurons” of the BLA to
facilitate fear extinction. Izumi and colleagues reported that an
amygdala-selective reduction of 5-HT content via site-speciﬁc
5,7-DHT injection reduced the expression of conditioned fear
responses in rats (Izumi et al., 2012). While this ﬁnding is
diﬃcult to reconcile with our report that 5-HT2AR activation
enhanced fear extinction, it is possible that the 5-HT denervation
may have increased postsynaptic expression of 5-HT2ARs in
the amygdala, which might in turn impair the expression of
fear. It is clear that further studies are needed to clarify the
neurophysiological inﬂuences of 5-HT, and the 5-HT2AR in
particular, on the neural circuitry supporting fear memory
encoding, consolidation, retrieval, and extinction.
The inﬂuence of the 5-HT2AR on the extinction and
reconsolidation of fear memory may have signiﬁcant impact on
the development of therapeutic approaches for subjects with
fear memory invasion, such as phobias and post trauma stress
disorder (Quirk et al., 2010). For decades, the pharmacological
manipulation of the 5-HT system has been a useful approach
to treat emotional and mental disorders, such as depression
and anxiety. Recent progress has suggested a promising
therapeutic application of hallucinogenic 5-HT2 agonists to
treat depression and anxiety (Grob et al., 2011). These results
suggest that despite the historical stigma associated with 5-
HT2AR activators as potential hallucinogens, such compounds
may provide important medical potential for treating aﬀective
and cognitive symptoms associated with emotional and mental
conditions.
Glutamatergic neurons in the amygdala, cortex and
hippocampus are essential for memory extinction and
reconsolidation. Local infusion of NMDAR antagonists
into the BLA or CA1 region of hippocampus before extinction
training suppresses fear memory extinction and reconsolidation
(Baker and Azorlosa, 1996; Szapiro et al., 2003). The NMDAR
partial agonist D-cycloserine facilitates the extinction of fear
memory (Walker et al., 2002; Ledgerwood et al., 2003). Knockout
of NMDAR in hippocampal CA1 pyramidal cells exclusively
impairs the establishment of conditioning between the CS and
the US during a trace fear conditioning task. These results suggest
that the CS representation and conditioning are entrained within
hippocampus cell ensembles, probably via NMDAR-dependent
synaptic plasticity (McHugh et al., 1996; Huerta et al., 2000).
Recall that 5-HT2ARs are expressed in the dendrites and
dendritic spines of dentate gyrus neurons where NMDARs
and AMPARs are assumed to be located (Peddie et al., 2008).
5-HT2AR activation produces an elevation in the frequency and
amplitude of cortical neuronal sEPSP/sEPSCs (Aghajanian and
Marek, 1999), facilitates NMDAR activity and synaptic plasticity
in the cortex (Arvanov et al., 1999) and BLA (Chen et al., 2003).
It is worth while to examine the degree to which NMDARs
expressed in the infralimbic and prelimbic cortices contribute to
the 5HT2AR-mediated enhancement in fear extinction.
Converging evidence demonstrates that activation of 5-
HT2ARs via systemic injection, or by local microinfusion,
appears to enhance two forms of hippocampal-dependent
memory in mice: object memory and conditioned fear memory.
Administration of a selective 5-HT2AR antagonist alone was
not found to signiﬁcantly aﬀect object memory or fear memory
(Zhang et al., 2013), suggesting that memory consolidation does
not require serotonergic activation of 5-HT2ARs and/or the
antagonists do not aﬀect the tonic eﬀect the 5-HT2AR. Activation
of 5-HT2ARs with TCB-2 was also found to facilitate fear memory
extinction in mice. These results oﬀer promising support for
the view that the 5-HT2AR may be an important new target for
consideration in the search for mechanisms by which long-term
memory can be enhanced in humans.
Hallucination vs. Spatial Cognition
5-HT2AR and Hallucination
Recent evidence suggests that activation of 5-HT2ARs may
promote experiencing visual hallucinations by increasing
neuronal excitability and altering visual-evoked cortical
responses (Kometer et al., 2013). Hallucination is a type of
misperception deﬁned as the perception of an object without
there being an object to perceive. Hallucinations are a signiﬁcant
characteristic found in a diversity of psychiatric and neurological
states. Hallucinations can be triggered by at least three categories
of drugs: psychedelics, (i.e., DOI, TCB-2, LSD, and psilocybin)
via activation of 5-HT2ARs, psychostimulants (i.e., cocaine or
amphetamine) via activation of dopamine D2 receptors and
dissociative anesthetics (i.e., phencyclidine or ketamine) via
blockade of glutamate NMDARs. The signaling and behavioral
responses to each hallucinogen are distinct from each other.
Activation of 5-HT2AR is critical for the psilocybin (found in
magic mushroom)-induced α oscillations, N170 visual-evoked
potentials, and visual hallucinations (Kometer et al., 2013).
5-hydroxytryptamine/serotonin is an endogenous
neurotransmitter and is not considered hallucinogenic.
Interesting, N-methyltryptamines, a metabolite of 5-HT, also
presents high aﬃnity for 5-HT2AR and can induce hallucinations
in a manner independent of β-arrestin2/phosphoinositide
3-kinase/Src/Akt cascade (Schmid and Bohn, 2010). Signaling for
hallucinogens is distinct. Lisuride (an antiparkinsonian agent)
and LSD both bind cortical 5-HT2AR, and thereby regulate
PLC activity. LSD signaling involves pertussis toxin-sensitive
heterotrimeric Gi/o proteins and Src (Gonzalez-Maeso et al.,
2007). Non-hallucinogenic agonists, for example lisuride, only
stimulate cortical Gq in rats, whereas hallucinogens such as
psilocybin (found in magic mushrooms), and LSD stimulate
both Gq/11 and Gi (Gonzalez-Maeso et al., 2007). The β-arrestin
pathway is involved in hallucinogen-mediated head shake
responses in rodents (Schmid et al., 2008), and 5-HT induces
a head shake response in mice via a β-arrestin-2-dependent
signaling. However, the DOI invoked head shake behavior is not
dependent upon β-arrestin-2 signaling. These ﬁndings suggest
that the 5-HT2AR-β-arrestin interaction may be exclusively for
endogenous 5-HT action. Further examination of hallucinogen-
mediated signaling may have major implications in drug
development for treating emotional and mental disorders such
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as depression and schizophrenia (Schmid et al., 2008). More
research eﬀorts will need to be focused on the hallucination-
inducing aspects of 5-HT2AR-sensitive drugs and, relevant to
their potential therapeutic potential, it may be important to
consider designing novel compounds that yield more of the
beneﬁcial eﬀects, without activating those problematic sensory
and perceptual eﬀects.
5-HT2AR-mediated Hallucination and Spatial
Cognition
5-HT2A receptors may aﬀect spatial cognition. A human
population-based study shows that 5-HT2AR TT genotype of
rs6313 is associated with better spatial cognitive performance
(Gong et al., 2011). Kant et al. (1998) reported that the 5-HT2AR
agonist DOI (0.1 and 0.25 mg/kg, 30 min pretreatment) slowed
rat performance as assessed by swim time on both a well-learned
water maze as well as learning of a new maze, but DOI did
not alter error rate on either task. Kant concluded that DOI
impaired performance by suppressing motor activity on a water
maze (Kant et al., 1998), which was in opposition to another
report showing that manipulation of 5-HT2AR did not impair
the latency to a visible platform water maze test (Naghdi and
Harooni, 2005). The serotonergic hallucinogens may impair the
hippocampal-dependent spatial cognition by acting on 5-HT2ARs
(Naghdi and Harooni, 2005). However, the direct evidence of 5-
HT2AR on visuospatial cognition and the central target has not
been determined.
Serotonergic psychedelics may aﬀect the integrity of visual
functioning. Visual-directed spatial cognition and navigation
are guided by exteroceptive (e.g., landmarks) and interoceptive
(e.g., self-motion information) cues, and their integration. The
hippocampus is a pivotal brain region receiving and integrating
information for spatial memory and navigation in rodents
(Broadbent et al., 2004; Eichenbaum, 2004). The MWM is
a classic behavioral task for testing hippocampal-dependent
visuospatial cognition, including place learning and memory,
orientation and decision-making (Morris et al., 1982; Morris,
1984). Further, hippocampal place cells exhibit location-speciﬁc
ﬁring, and are considered to be fundamental components of
network for spatial problem solving in the mammalian brain
(for a review see Moser et al., 2008). The hippocampal neural
circuit representing current location, directional heading and
its integration is inﬂuenced by exteroceptive and interoceptive
cues, and is considered to guide spatial cognition and
navigation.
We recently found that pre-test activation of 5-HT2AR with
TCB-2 signiﬁcantly delayed the initiation of an accurate search
path by well-trained male mice in the hidden platform MWM
(Zhang et al., 2015). Importantly, 5-HT2AR activation did
not aﬀect swim performance or visual cue-triggered approach
behavior in the visible platform water maze task. Taken together,
our results suggest that the activation of 5-HT2AR impairs
the retrieval of hippocampal spatial memory, but not the
accuracy of spatial information retrieval and decision-making.
It is conceivable that the delayed initiation of accurate spatial
search by TCB-2-treated mice might reﬂect the possible visual
hallucinatory inﬂuences of the 5-HT2AR agonist. For example,
perhaps TCB-2-induced a brief aberration of visual input that
slowed the perception of current position and local view of
the mouse at the start of the water maze probe test. Once,
reconciled or reoriented, the mouse was able to swim accurately
to the remembered spatial location of the platform. It will
be of interest to determine where in the brain TCB-2 is
acting to alter spatial memory retrieval. The relatively weak
inﬂuence of TCB-2-induced visual hallucination on spatial
navigation may due to the diﬀerence in the visual information
passing through the brain and central targets processing the
information.
Taken together, the results we have reported here of memory
eﬀects after activation of the 5-HT2AR represent a fairly complex
picture. The post-training administration of TCB-2 enhanced
consolidation of object memory in mice. Pre-test administration
of TCB-2 did not aﬀect retrieval of object memory, yet
delayed retrieval of spatial memory. Pre-extinction training
administration of TCB-2 facilitated the acquisition of extinction
of both trace and delay fear memories. The facilitating eﬀect of
TCB-2 on fear extinction may have been the result of a combined
eﬀect of suppressing fear expression – possibly a consequence of
impaired retrieval of fear memory, and enhancing the encoding
and consolidation of fear extinction. To characterize the 5-
HT2AR agonist as a cognitive enhancer based solely on our
object memory results, would be to ignore the other experimental
ﬁndings. We are interested in conducting a more comprehensive
analysis of the impact of TCB-2 on multiple forms of memory.
For example, it will be interesting to examine whether post-
conditioning TCB-2 might enhance the consolidation of fear
memory, in a manner consistent with that observed in the
NOR task. Likewise, it will be interesting to test whether post-
extinction training TCB-2 facilitates the consolidation of fear
extinction. Results of these experiments will help in better
appreciating the modulatory inﬂuence of the 5-HT2AR on long-
term memory processes. This synthesis of recent ﬁndings of
the inﬂuences of 5-HT2AR activation should provide a credible
argument that the 5-HT2AR participates signiﬁcantly to the
well-documented contribution of 5-HT to memory (Meneses,
2013).
5-HT2AR and Mental Disorders
A number of psychiatric and neurodegenerative disorders are
associated with the variation of structure, expression, and
function of 5-HT2ARs. Positron emission tomography (PET)
molecular imaging has the sensitivity to quantify binding of 5-
HT2ARs in CNS disorders. Medication-free depressed subjects
presented greater 5-HT2AR binding (Bhagwagar et al., 2006).
There was a signiﬁcant reduction in 5-HT2AR binding in frontal
polar, dorsolateral and medial frontal cortex, and parietal and
temporal associative cortex of OCD patients and a signiﬁcant
correlation between 5-HT2AR availability in orbitofrontal and
dorsolateral frontal cortex and clinical severity (Perani et al.,
2008). Schizophrenia patients present with very high 5HT2AR
occupancy in the frontal cortex (Talvik-Lotﬁ et al., 2000). These
results suggest that the variation in the number, aﬃnity and/or
function of 5-HT2AR participates in the etiology of mental
disorders.
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Alzheimer’s Disease
It is interesting to note that neocortical 5-HT2AR binding is
signiﬁcantly decreased in patients with early stage AD, and in
those with mild cognitive impairment; especially in temporal
lobe regions associated with long-term memory (Meltzer et al.,
1998; Hasselbalch et al., 2008; Santhosh et al., 2009; Marner et al.,
2011, 2012). Further, the severity of cognitive impairment in
AD patients correlates with the decrease in 5-HT2AR binding
(Versijpt et al., 2003). Given the pattern of 5-HT2AR distribution
in neocortical regions and their expression on principal excitatory
neurons, it is possible that the marked reduction in 5-HT2AR
in brains of AD is a direct product of neuron loss in key
brain regions. Consistent with evidence from the human studies,
the Alzheimer’s-like neuropathology and associated memory
deﬁcits in rodents, which follow intra-hippocampal injection of
ß-amyloid(1-42), are associated with a signiﬁcant reduction in
levels of hippocampal 5-HT2AR expression (Christensen et al.,
2008). Although we have focused this analysis on the inﬂuence
of 5-HT2ARs on long-term, hippocampal-dependent memory,
there is clear and compelling evidence to suggest that the 5-
HT2AR represents a potential new target by which human long-
term memory may be modulated. We assert that it will be
of interest in further examine the contribution of 5-HT2ARs
to memory processes, and we are particularly interested in
determining neurophysiological inﬂuences of 5-HT2AR agonists
which promote the enhancement of memory consolidation which
we have reported in mice.
Drug Memory
Drug dependence, classiﬁed as an impulsive, compulsive, and
relapsing psychiatric disorder, represents a devastating societal
problem worldwide. The profound symptoms of drug abuse, in
particular the cue-elicited relapse to drug use after even long
periods of abstinence, are a consequence of robust experience-
dependent synaptic plasticity within the brain’s reward circuit.
Like episodic, semantic, and habit memory, drug-associated
memories are persistent and hold a strong inﬂuence on
current and future behaviors. Of particular interest is the
consideration of memory extinction as a psychological tool
for remediating the problem of relapse in drug addicts. That
is, if the problem of drug abuse is approached as a mental
disorder of memory, then pharmacological manipulations that
facilitate extinction may hold therapeutic utility for treating
drug abuse. Drug exposure alters the expression and function
of 5-HT2AR, for example morphine decreases frontocortical
5-HT2AR binding aﬃnity in dogs (Adriaens et al., 2012). 5-
HT2Rs are up-regulated in amygdala, midbrain, pons, and
medulla of morphine-tolerant and -dependent rats, but not
in morphine-abstinent rats (Gulati and Bhargava, 1989).
There is considerable evidence that 5-HT2ARs modulate the
behavioral consequences of repeated exposure to addictive
psychomotor stimulants. For example, M100907 suppresses
hyperactivity elicited by cocaine (Fletcher et al., 2002), MK-
801, amphetamine (O’Neill et al., 1999), and morphine
(Auclair et al., 2004). DOM, a 5-HT2AR agonist, attenuates
locomotor-stimulating eﬀects of morphine, which could be
prevented by M100907 (Li et al., 2013). Furthermore, M100907
attenuated the ability of experimenter-administered cocaine to
reinstate lever pressing (Fletcher et al., 2002) and attenuated
the drug associated cue-induced reinstatement of cocaine-
seeking behavior after extinction (Nic Dhonnchadha et al.,
2009). M100907 also suppressed reinstatement induced by
nicotine prime or nicotine-associated cue (Fletcher et al.,
2012) and sensitization (Zaniewska et al., 2010). Intra-NAc
infusions of M 100907 blocked the expression of cocaine-
induced locomotor sensitization (Zayara et al., 2011). Intra-
PFC M100907 decreased cue-elicited reinstatement of cocaine
seeking-behavior (Pockros et al., 2011). Together, these results
suggest that 5-HT2ARs modulate drug addiction-dependent
behaviors such as craving and drug-seeking and pharmacological
blockade of 5-HT2ARs may represent a therapeutic advance
in suppression of cue-evoked craving and/or relapse in drug
addicts.
Therapeutic Application of 5-HT2AR
Preclinical and clinical studies have provided support for the
use of pharmacological manipulation of 5-HT2AR to treat
the symptoms of mental disorders. Activation of 5-HT2AR
with TCB-2 in the medial septum-diagonal band of Broca
complex enhances neuronal activity and working memory in
hemiparkinsonian rats (Li et al., 2015). M100907 had no
eﬀect on attentional performance, but abolished the PCP-
induced attentional performance deﬁcits in rats (Poyurovsky
et al., 2003). M100907 prevents impairment in attentional
performance by NMDAR blockade in the rat PFC (Mirjana
et al., 2004). There are a number of 5-HT2AR drugs that have
been evaluated or are being currently evaluated under clinical
trials, for example quetiapine1 for schizophrenia; M1009072
for depression; ACP-1033 for Parkinson’s disease; pimavanserin
for patients with AD psychosis4 or with Parkinson’s disease
psychosis5.
Conclusion
In this review, we have summarized recent progress in the
signaling, polymerization and allosteric modulation of 5-HT2AR;
and have discussed the critical role of 5-HT2ARs in a number
of cognitive processes. Based on the results of studies from
our lab and others, it appears that activation of 5-HT2ARs
may oﬀer a novel approach to treat the impairment of
learning and memory associated with several neurodegenerative
disorders. Meanwhile, blockade of 5-HT2AR may oﬀer a
feasible way to suppress drug craving and/or relapse. It will
be very interesting to identify the corresponding signaling
pathways by which 5-HT2ARs modulate these behavioral
capacities. Of particular note, we reviewed evidence that
5-HT2ARs may dimerize with other receptors, and that
certain pathways may promote constitutive activation of
1https://clinicaltrials.gov/ct2/show/NCT00207064?term=5-HT2A&rank=2
2https://clinicaltrials.gov/ct2/show/NCT00070694?term=5-HT2A&rank=5
3https://clinicaltrials.gov/ct2/show/NCT00086294?term=5-HT2A&rank=12
4https://clinicaltrials.gov/ct2/show/NCT02035553?term=5-HT2A&rank=41
5https://clinicaltrials.gov/ct2/show/NCT00477672?term=5-HT2A&rank=46
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5-HT2ARs, which likely represent novel receptor signaling
inﬂuences. Connecting such novel properties of 5-HT2ARs to
distinct functional consequences of 5-HT-, or agonist-, speciﬁc
activation of the 5-HT2ARs will be important for improving
understanding the myriad inﬂuences of 5-HT2ARs in the CNS.
The development of highly selective 5-HT2AR ligands will be
essential for further establishing the critical involvement of the
5-HT2AR for a number of fundamental cognitive behaviors.
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